Security key
98422E103
Xeris Biopharma Holdings, Inc. - Common Stock (XERS)
CUSIP: 98422E103
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 57,306,752
- Total 13F value
- $89,403,802
- Share change
- -2,104,910
- Put/Call ratio
- 17%
- SEC-reported price per share
- $1.56
- Number of holders
- 97
- Value change
- -$3,332,109
- Number of buys
- 37
- Number of sells
- 37
- Shares outstanding
- 165,974,436
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
97
Top holders
10
XERS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Xeris Biopharma Holdings, Inc. SEC filings
Xeris Biopharma Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98422E103
Recent filing periods:
Ownership snapshot
Top reported holders of XERS - Xeris Biopharma Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Stonepine Capital Managem...
Disclosed value leader
Stonepine Capital Managem...
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 7%
Showing 1-6 of 15 holder rows.
Quick read
Stonepine Capital Management, LLC leads the comparable SEC ownership view at 7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Stonepine Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
Stonepine Capital Management, LLC
7%
BlackRock Finance, Inc.
4.8%
VANGUARD GROUP INC
3.8%
CAXTON CORP
3.6%
ARMISTICE CAPITAL, LLC
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC |
13F
Company
|
7%
|
$17,937,000
11,647,417 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
4.8%
|
$12,331,000
8,006,794 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
3.8%
|
$9,692,000
6,293,481 shares
|
— | 30 Jun 2022 |
| CAXTON CORP |
13F
Company
|
3.6%
|
$9,300,000
6,039,028 shares
|
— | 30 Jun 2022 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
3.5%
|
$8,969,000
5,824,000 shares
|
— | 30 Jun 2022 |
| NEA Management Company, LLC |
13F
Company
|
2%
|
$5,000,000
3,246,785 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
97
Shares
57,306,752
Rows available
97
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
95
Q3 2022 holders
97
Holder diff
2
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend